Whether ahead of their time, truly bizarre, or just plain doomed, it’s certainly interesting to see companies go completely ...

Germany is widely recognized as one of the leading countries in the pharmaceutical industry boasting a rich history of innovation cutting-edge research and global influence With its well-established i ...

Nearly 12 months later, green shoots may finally be appearing following a desperately dark time for the German group that invented aspirin ... Bayer’s ability to profit off the drug.

In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.

Bayer was founded in the year 1863 in Barmen in North Rhine Westphalia in the west of what was then the Kingdom of Prussia, today modern Germany. "What started as a small but innovative dyestuffs ...

Bayer is pressing ahead with a phase ... with prior ischaemic stroke or high-risk TIA, on top of aspirin and antiplatelet therapy. The drug numerically reduced the risk of clinical ischaemic ...

Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...

The findings were based on observational data for 13,500 people ages 70 and older who had participated in the ASPREE trial of aspirin ... even in drug classes like fluoroquinolones or ...

These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

Investments in R&D and market expansion, particularly in emerging regions, will be crucial in shaping the future of the aspirin marketDublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Aspirin Global ...